PALO ALTO, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical research organization, ...

Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...

Changes in two genes appear to help predict whether patients will lose substantial weight on GLP-1 drugs — and whether the ...

The reasons why people have such varied experiences has been unclear, though new research from the 23andMe genetic testing ...

Subscribe to The Post Most newsletter for the most important and interesting stories from The . The GLP-1 weight loss drugs ...

Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?

Canadians who used 23andMe to learn about their family ancestry could have money coming their way due to a class-action ...

Why do Ozempic and Zepbound work differently for everyone? A new study identifies genetic variants linked to GLP-1 weight loss and side effects.

New findings could partially help explain why some people appear to lose weight more quickly than others while taking the ...

A new study identified genetic variants that researchers say can affect the results from taking a GLP-1 drug.

Add Yahoo as a preferred source to see more of our stories on Google. 23andMe headquarters in Sunnyvale, Calif. (Tayfun Coskun/Anadolu via Getty Images) Today is the deadline for customers of the ...

New York and 27 other states sued bankrupt genetic testing company 23andMe to block the sale of 15 million customers' ...